[葡萄糖皮质醇诱导骨质疏松症的诊断和治疗指南]
1Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing 100044, China.
Zhonghua nei ke za zhi
|June 1, 2023
概括
葡萄糖皮质醇诱导的骨质疏松症 (GIOP) 是一种常见的二次骨疾病. 该标准旨在改善中国的GIOP诊断和治疗.
科学领域:
- 类风湿病学 类风湿病学
- 内分泌学 在内分泌学.
- 骨的新陈代谢 骨的新陈代谢
背景情况:
- 葡萄糖皮质激素诱导的骨质疏松症 (GIOP) 是一种与长期葡萄糖皮质激素治疗相关的流行骨疾病,显著影响患者的生活质量.
- GIOP是最常见的二次骨质疏松症形式,对公共卫生构成重大挑战.
- 中国的GIOP发病率很高,伴随着不充分的认识和缺乏标准化的预防和治疗指南.
研究的目的:
- 建立一个全面的标准,用于中国的预防和治疗GIOP.
- 提高临床意识,指导GIOP的标准化诊断和管理.
- 为了改善患有葡萄糖皮质醇诱导骨质疏松症的患者的整体预后.
主要方法:
- 基于对国内和国际经验的审查,制定临床指南.
- 在中国风湿病学协会的专家之间建立共识.
- 整合基于证据的诊断和治疗实践.
主要成果:
- 已经建立了一个用于预防和治疗GIOP的标准化框架.
- 这些指导方针旨在解决目前中国对GIOP的认识和管理方面的差距.
- 预期的结果是改善临床实践和患者的治疗结果.
结论:
- 新成立的标准为管理GIOP的临床医生提供了必要的指导.
- 该标准的实施对于改善中国GIOP的预防,诊断和治疗至关重要.
- 该倡议旨在减轻GIOP对患者和医疗保健系统的重大负担.
更多相关视频
09:02Cortical Bone Assessment Using Ultrasonic Guided Waves: A Reproducibility Study in a Healthy Population
Published on: January 31, 2025
555
11:47A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
11.7K
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
161
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
161
COPD: Management Using Bronchodilators and Corticosteroids
256
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
256
Hypoglycemia and Glucagon
306
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
306
Osteoclasts in Bone Remodeling
3.0K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.0K
Bone Disorders
3.7K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.7K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
205
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
205
